Intrinsiqs

Is SpyGlass Pharma, Inc. Common Stock overvalued?

SpyGlass Pharma, Inc. Common Stock (SGP) — key valuation metrics and fundamentals.

No verdict
Price
$26.20
Fair value
Current P/E
Normal P/E
Market cap
$876.0M
Dividend yield
0.0%
Return on equity
-62.4%
Sector
Healthcare

See the full interactive analysis →

Fair value compares SGP's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.